DiaMedica Therapeutics Inc. (DMAC) Deferred Tax Assets, Valuation Allowance USD 2017 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
DiaMedica Therapeutics Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2017 to 2023.
  • DiaMedica Therapeutics Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $28 M, a 23.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $28 M +$5.3 M +23.3% Dec 31, 2023 10-K 2024-03-19
Q4 2022 $22.7 M +$3.34 M +17.2% Dec 31, 2022 10-K 2024-03-19
Q4 2021 $19.4 M +$3.13 M +19.2% Dec 31, 2021 10-K 2023-03-28
Q4 2020 $16.3 M +$3.53 M +27.8% Dec 31, 2020 10-K 2022-03-14
Q4 2019 $12.7 M +$1.85 M +17% Dec 31, 2019 10-K 2021-03-10
Q4 2018 $10.9 M +$2.33 M +27.3% Dec 31, 2018 10-K 2020-03-23
Q4 2017 $8.55 M Dec 31, 2017 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.